This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (196)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A. T. Marcel Gosselink, MD; Harry J. G. M. Crijns, MD; Isabelle C. Van Gelder, MD; Hans Hillige, MD; Ans C. P. Wiesfeld, MD; Kong I. Lie, MD

JAMA. 1992;267(24):3289-3293.

Abstract
Objective.
—To study efficacy and safety of low-dose amiodarone for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation or flutter.

Design.
—Nonrandomized trial; mean duration of follow-up, 20.7 months.

Setting.
—Referral center; institutional practice; both hospitalized and ambulatory care.

Patients.
—Eighty-nine consecutive patients having chronic atrial fibrillation or flutter and eligible for cardioversion. Patients had failed previous treatment aimed at maintaining sinus rhythm. During follow-up one patient was withdrawn because of side effects; all patients were available for follow-up.

Intervention.
—Before cardioversion, patients received 600 mg of amiodarone daily during a 4-week loading period. After conversion, the daily maintenance dose was 204±66 mg (mean±SD).

Main Outcome Measures.
—Arrhythmia recurrence and adverse effects causing drug discontinuation.

Results.
—During loading, 15 patients (16%) converted, and after electrical cardioconversion, 90% of all patients had sinus rhythm. Actuarially, 53% of these patients were still in sinus rhythm after 3 years. In patients with compromised left ventricular function, 93% maintained sinus rhythm after 6 months. One patient died due to congestive heart failure. Intolerable side effects occurred in one patient. No proarrhythmia was observed. Logistic regression analysis revealed that amiodarone was ineffective in patients with mitral stenosis or chronic arrhythmia.

Conclusions.
—Low-dose amiodarone is effective for maintaining sinus rhythm in patients with difficult to treat chronic atrial fibrillation or flutter and is associated with a low incidence of serious side effects.

(JAMA. 1992;267:3289-3293)

Author Affiliations
From the Department of Cardiology, Thoraxcentrum, University Hospital Groningen (the Netherlands).

Footnotes
Reprint requests to Department of Cardiology, University Hospital Groningen, PO Box 30 001, 9700 RB Groningen, the Netherlands (Dr Gosselink).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study)
Shelton et al.
Heart 2009;95:924-930.
ABSTRACT | FULL TEXT  

Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications
Vassallo and Trohman
JAMA 2007;298:1312-1322.
ABSTRACT | FULL TEXT  

Results From the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) Trial on Atrial Flutter, a Multicentric Prospective Randomized Study Comparing Amiodarone and Radiofrequency Ablation After the First Episode of Symptomatic Atrial Flutter
Da Costa et al.
Circulation 2006;114:1676-1681.
ABSTRACT | FULL TEXT  

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:651-745.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:854-906.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:e149-e246.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:e257-e354.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:700-752.
FULL TEXT  

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Authors/Task Force Members et al.
Eur Heart J 2006;27:1979-2030.
FULL TEXT  

Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
Gulizia et al.
Europace 2006;8:302-305.
ABSTRACT | FULL TEXT  

Usefulness of Ambulatory 7-Day ECG Monitoring for the Detection of Atrial Fibrillation and Flutter After Acute Stroke and Transient Ischemic Attack
Jabaudon et al.
Stroke 2004;35:1647-1651.
ABSTRACT | FULL TEXT  

Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting
Yagdi et al.
J. Thorac. Cardiovasc. Surg. 2003;125:1420-1425.
ABSTRACT | FULL TEXT  

Emergency management of atrial fibrillation
Wakai and O'Neill
Postgrad. Med. J. 2003;79:313-319.
ABSTRACT | FULL TEXT  

What is the optimal electrode configuration for atrial defibrillators in man?
Mitchell et al.
Europace 2002;4:41-44.
FULL TEXT  

Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial
Galperin et al.
J CARDIOVASC PHARMACOL THER 2001;6:341-350.
ABSTRACT  

Paroxysmal atrial fibrillation
Lip and Hee
QJM 2001;94:665-678.
ABSTRACT | FULL TEXT  

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
Circulation 2001;104:2118-2150.
FULL TEXT  

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur Heart J 2001;22:1852-1923.
 

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
J Am Coll Cardiol 2001;38:1231-1265.
FULL TEXT  

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
J Am Coll Cardiol 2001;38:1266-1266.
FULL TEXT  

Electrophysiologic and Antiarrhythmic Effects of the New Class III Antiarrhythmic Drug KCB-328 in Experimental Canine Atrial Flutter
Rahme et al.
J CARDIOVASC PHARMACOL THER 2001;6:297-306.
ABSTRACT  

Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy
Pedersen et al.
Circulation 2001;104:292-296.
ABSTRACT | FULL TEXT  

Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion
Lombardi et al.
J Am Coll Cardiol 2001;37:157-162.
ABSTRACT | FULL TEXT  

Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting
Lee et al.
Ann. Thorac. Surg. 2000;70:157-161.
ABSTRACT | FULL TEXT  

Effects of the Maze Operation on Health-Related Quality of Life in Patients With Atrial Fibrillation
Lonnerholm et al.
Circulation 2000;101:2607-2611.
ABSTRACT | FULL TEXT  

Atrial fibrillation in dialysis patients
Zebe
Nephrol Dial Transplant 2000;15:765-768.
FULL TEXT  

Amiodarone as a First-Choice Drug for Restoring Sinus Rhythm in Patients With Atrial Fibrillation : A Randomized, Controlled Study
Vardas et al.
Chest 2000;117:1538-1545.
ABSTRACT | FULL TEXT  

Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations
Dorge et al.
Ann. Thorac. Surg. 2000;69:1358-1362.
ABSTRACT | FULL TEXT  

Systematic review of the management of atrial fibrillation in patients with heart failure
Khand et al.
Eur Heart J 2000;21:614-632.
ABSTRACT  

Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy et al.
NEJM 2000;342:913-920.
ABSTRACT | FULL TEXT  

Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation
Capucci et al.
Eur Heart J 2000;21:66-73.
ABSTRACT  

Electrophysiological and Antiarrhythmic Effects of the Atrial Selective 5-HT4 Receptor Antagonist RS-100302 in Experimental Atrial Flutter and Fibrillation
Rahme et al.
Circulation 1999;100:2010-2017.
ABSTRACT | FULL TEXT  

Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation
Tuinenburg et al.
Heart 1999;82:486-493.
ABSTRACT | FULL TEXT  

Atrial Fibrillation in Heart Failure
Stevenson and Stevenson
NEJM 1999;341:910-911.
FULL TEXT  

Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man
Kamalvand et al.
Eur Heart J 1999;20:888-895.
ABSTRACT  

Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation
Catherwood et al.
ANN INTERN MED 1999;130:625-636.
ABSTRACT | FULL TEXT  

Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study
Kochiadakis et al.
J Am Coll Cardiol 1999;33:966-971.
ABSTRACT | FULL TEXT  

Spontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation : Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT)
Deedwania et al.
Circulation 1998;98:2574-2579.
ABSTRACT | FULL TEXT  

Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention
Delfaut et al.
J Am Coll Cardiol 1998;32:1900-1908.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
Eckman et al.
Arch Intern Med 1998;158:1669-1677.
ABSTRACT | FULL TEXT  

Clinical Review : Update on Atrial Fibrillation: Restoration of Sinus Rhythm or Ventricular Rate Control?
Li and Hohnloser
J CARDIOVASC PHARMACOL THER 1998;3:185-194.
ABSTRACT  

Atrial Fibrillation: Defining Some Unanswered Questions
Singh and Lopez
J CARDIOVASC PHARMACOL THER 1998;3:195-199.
 

Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery
Daoud et al.
NEJM 1997;337:1785-1791.
ABSTRACT | FULL TEXT  

Assessment of Atrioventricular Junction Ablation and DDDR Mode-Switching Pacemaker Versus Pharmacological Treatment in Patients With Severely Symptomatic Paroxysmal Atrial Fibrillation : A Randomized Controlled Study
Brignole et al.
Circulation 1997;96:2617-2624.
ABSTRACT | FULL TEXT  

The Management of Hypertrophic Cardiomyopathy
Spirito et al.
NEJM 1997;336:775-785.
FULL TEXT  

Chronic Atrial Fibrillation: Success of Serial Cardioversion Therapy and Safety of Oral Anticoagulation
Van Gelder et al.
Arch Intern Med 1996;156:2585-2592.
ABSTRACT  

The antiarrhythmic treatment of atrial fibrillation
DTB 1996;34:41-45.
ABSTRACT | FULL TEXT  

Management of Patients With Atrial Fibrillation : A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
Prystowsky et al.
Circulation 1996;93:1262-1277.
FULL TEXT  

Treatment of Resistant Atrial Fibrillation: A Meta-analysis Comparing Amiodarone and Flecainide
Zarembski et al.
Arch Intern Med 1995;155:1885-1891.
ABSTRACT  

Antiarrhythmic Prophylaxis vs Warfarin Anticoagulation to Prevent Thromboembolic Events Among Patients With Atrial Fibrillation: A Decision Analysis
Middlekauff et al.
Arch Intern Med 1995;155:913-920.
ABSTRACT  

Evolving Strategies for the Management of Atrial Fibrillation: The Role of Amiodarone
Estes
JAMA 1992;267:3332-3333.
ABSTRACT